Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000205799 | SCV000259574 | likely benign | Familial adenomatous polyposis 2 | 2025-01-08 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV000222680 | SCV000274113 | likely benign | Hereditary cancer-predisposing syndrome | 2015-02-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Color Diagnostics, |
RCV000222680 | SCV000907353 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-20 | criteria provided, single submitter | clinical testing | |
| All of Us Research Program, |
RCV000205799 | SCV004841838 | likely benign | Familial adenomatous polyposis 2 | 2023-08-15 | criteria provided, single submitter | clinical testing |